Literature DB >> 2844752

Glycosylation of the basic fibroblast growth factor receptor. The contribution of carbohydrate to receptor function.

J J Feige1, A Baird.   

Abstract

We have examined the glycosylation of the basic fibroblast growth factor (bFGF) receptor to determine whether carbohydrates contribute to receptor structure and function. Using a combination of cross-linking and radioreceptor assays, we demonstrated that the two bFGF receptors in baby hamster kidney cells have protein cores of 100 and 125 kDa. They are glycosylated to high mannose forms of 115 and 140 kDa and further processed to their mature forms of 130 and 150 kDa. Because peptide:N-glycosidase F, but not endo-alpha-N-acetylgalactosamidase can reduce the size of the bFGF receptors, the carbohydrate residues of the receptor appear all N-linked. The inability of deglycosylated receptors to bind 125I-bFGF supports the notion that the carbohydrate residues are required for receptor function. Furthermore, the capacity of the wheat germ agglutinin lectin to inhibit 125I-bFGF binding and the biological activity of bFGF suggests that N-acetylglucosamine residues are functionally significant components of the receptor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844752

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG).

Authors:  M Ruta; W Burgess; D Givol; J Epstein; N Neiger; J Kaplow; G Crumley; C Dionne; M Jaye; J Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Heparin-binding growth factors and their receptors.

Authors:  B B Olwin
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

3.  Effect of fibroblast growth factor saporin mitotoxins on human bladder cell lines.

Authors:  T A Tetzke; M C Caton; P A Maher; Z Parandoosh
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

4.  Related fibroblast growth factor receptor genes exist in the human genome.

Authors:  E Houssaint; P R Blanquet; P Champion-Arnaud; M C Gesnel; A Torriglia; Y Courtois; R Breathnach
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  High molecular weight FGF2 isoforms demonstrate canonical receptor-mediated activity and support human embryonic stem cell self-renewal.

Authors:  Denis Kole; Alexandra Grella; David Dolivo; Lucia Shumaker; William Hermans; Tanja Dominko
Journal:  Stem Cell Res       Date:  2017-04-18       Impact factor: 2.020

6.  Nucleoside/nucleotide reverse transcriptase inhibitors attenuate angiogenesis and lymphangiogenesis by impairing receptor tyrosine kinases signalling in endothelial cells.

Authors:  Lin Song; Sha Ding; Zhen Ge; Xiaolong Zhu; Cong Qiu; Yuewen Wang; Enyin Lai; Weijun Yang; Yi Sun; Samson A Chow; Luyang Yu
Journal:  Br J Pharmacol       Date:  2017-10-25       Impact factor: 8.739

7.  Identification of soluble forms of the fibroblast growth factor receptor in blood.

Authors:  A Hanneken; W Ying; N Ling; A Baird
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

8.  Survival of purified rat photoreceptors in vitro is stimulated directly by fibroblast growth factor-2.

Authors:  V Fontaine; N Kinkl; J Sahel; H Dreyfus; D Hicks
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

9.  Herpes simplex virus infection can occur without involvement of the fibroblast growth factor receptor.

Authors:  M I Muggeridge; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

10.  2-Deoxy-Glucose Downregulates Endothelial AKT and ERK via Interference with N-Linked Glycosylation, Induction of Endoplasmic Reticulum Stress, and GSK3β Activation.

Authors:  Krisztina Kovács; Christina Decatur; Marcela Toro; Dien G Pham; Huaping Liu; Yuqi Jing; Timothy G Murray; Theodore J Lampidis; Jaime R Merchan
Journal:  Mol Cancer Ther       Date:  2015-12-04       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.